http://www.unboundmedicine.com/medline/ebm/research/temsirolimusUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19891127/full_citation/Novel_antiangiogenic_agents_in_the_treatment_of_refractory_renal_cell_carcinoma_Sonpavde G, Hutson TE 
Novel antiangiogenic agents in the treatment of refractory renal cell carcinoma. [Journal Article]
Clin Genitourin Cancer 2008 Dec.:S29-36.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19891125/full_citation/What_role_do_combinations_of_interferon_and_targeted_agents_play_in_the_first_line_therapy_of_metastatic_renal_cell_carcinomaBukowski RM 
What role do combinations of interferon and targeted agents play in the first-line therapy of metastatic renal cell carcinoma? [Journal Article]
Clin Genitourin Cancer 2008 Dec.:S14-21.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19891124/full_citation/Current_algorithms_and_prognostic_factors_in_the_treatment_of_metastatic_renal_cell_carcinoma_Molina AM, Motzer RJ 
Current algorithms and prognostic factors in the treatment of metastatic renal cell carcinoma. [Journal Article]
Clin Genitourin Cancer 2008 Dec.:S7-13.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19860903/full_citation/Targeting_tumorigenesis:_development_and_use_of_mTOR_inhibitors_in_cancer_therapy_Yuan R, Kay A, Berg WJ, et al. 
Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy. [JOURNAL ARTICLE]
J Hematol Oncol 2009 Oct 27; 2(1):45.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19855161/full_citation/The_role_of_mTORC1_pathway_in_intestinal_tumorigenesis_Fujishita T, Aoki M, Taketo MM 
The role of mTORC1 pathway in intestinal tumorigenesis. [JOURNAL ARTICLE]
Cell Cycle 2009 Nov 28; 8(22)
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19808140/full_citation/Comparison_of_temsirolimus_pharmacokinetics_in_patients_with_renal_cell_carcinoma_not_receiving_dialysis_and_those_receiving_hemodialysis:_a_case_series_Lunardi G, Armirotti A, Nicodemo M, et al. 
Comparison of temsirolimus pharmacokinetics in patients with renal cell carcinoma not receiving dialysis and those receiving hemodialysis: a case series. [Journal Article]
Clin Ther 2009 Aug; 31(8):1812-9.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19804430/full_citation/Cost_Effectiveness_of_Temsirolimus_for_First_Line_Treatment_of_Advanced_Renal_Cell_Carcinoma_Hoyle M, Green C, Thompson-Coon J, et al. 
Cost-Effectiveness of Temsirolimus for First Line Treatment of Advanced Renal Cell Carcinoma. [JOURNAL ARTICLE]
Value Health 2009 Sep 25.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19757306/full_citation/Exploring_mammalian_target_of_rapamycin__mTOR__inhibition_for_treatment_of_mantle_cell_lymphoma_and_other_hematologic_malignancies_Coiffier B, Ribrag V 
Exploring mammalian target of rapamycin (mTOR) inhibition for treatment of mantle cell lymphoma and other hematologic malignancies. [JOURNAL ARTICLE]
Leuk Lymphoma 2009 Sep 8.:1-15.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19752718/full_citation/New_treatment_approaches_in_renal_cell_carcinoma_Facchini G, Perri F, Caraglia M, et al. 
New treatment approaches in renal cell carcinoma. [JOURNAL ARTICLE]
Anticancer Drugs 2009 Sep 11.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19748725/full_citation/Metastatic_Renal_Cell_Carcinoma:_Recent_Advances_in_the_Targeted_Therapy_Era_Di Lorenzo G, Autorino R, Sternberg CN 
Metastatic Renal Cell Carcinoma: Recent Advances in the Targeted Therapy Era. [JOURNAL ARTICLE]
Eur Urol 2009 Sep 8.
Abstract | Full Citation | Find Related Articles